DSIJ Mindshare

Pharma Major Shares Rebound from Lows; Firm Reports 39.5 per cent Profit Growth

The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24

Abhishek Wani 0 175 Article rating: 5.0

The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24

This pharma company stock went 8 per cent high, do you own it?

With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

Kiran Shroff 0 1380 Article rating: 5.0

This pharma company stock went 8 per cent high, do you own it?                                                                                                                                                                                                       With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

A Volatile End: Nifty closes below 18,200 amid volatility; Realty, Pharma and metals take a hit

Nifty PSU Bank (+3.93 per cent) emerged as the top performers amongst the sectoral indices.  

Rohit Kale 0 960 Article rating: 3.5

NSE Nifty 50 index plunged 0.25 per cent to close below 18,200 level while Sensex slipped 150 points. Nifty Midcap and Nifty Smallcap closed lower by 0.74 per cent and 0.56 per cent respectively.

Overnight Digest: Watch out for these stocks on September 30

Keep an eye on these stocks for Friday's trading session.

Shreya Chaware 0 2577 Article rating: 4.4

The weakening global economic environment has spiked up the bond yields and dollar index, which fostered fears of recession. Fading the morning losses, the benchmark indices ended marginally lower with Nifty 50 closing 0.24 per cent down and Sensex ending lower by 0.33 per cent.  

RSS
123
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR